# SILDENAFIL CITRATE
> **ANDA209302** · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA · Approved 2020-08-25
## Drug
- **FDA Application Number:** ANDA209302
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** SILDENAFIL CITRATE
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UMEDICA
- **Manufacturer:** Umedica Laboratories USA Inc.
- **First approval:** 2020-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209302)
---
*AI Analytics · CC0 1.0*